2009 Access DEA Safety 
Cannabis Law Report
JULY 9, 2021
Right to Try laws permit patients with serious or life-threatening diseases to access drugs that do not yet have government approval. Drug Enforcement Agency (“DEA”). Briefing is still under way, with the DEA’s responsive brief submitted on June 25, 2021, and the petitioners’ reply due July 16, 2021. AIMS Institute, PLLC.
Cannabis Law Report
APRIL 8, 2022
Later that year, Doblin sued the DEA for the first time. The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. submitted his first DEA application to manufacture marijuana for use in medical research.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Meadow
JULY 13, 2018
we want everyone who did not have the opportunity to attend Meadowlands to have access to this content. I moved to San Francisco in 2006 and started my time in city government in 2009, so I spent over a decade in city hall working for two administrations. So please feel free to share this post with your network and your community?—?we
Cannabis Law Report
MARCH 25, 2019
The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. But DEA regulators determined after both of those reviews that marijuana should remain a Schedule I substance. 2(f)(1), May 20, 2009 , 123 Stat. 2(f)(2), May 20, 2009 , 123 Stat. 1664 , 1857, 1858, 1870; Pub.
Cannabis Law Report
AUGUST 5, 2021
Regulatory authority would move from the DEA to the FDA, but also the ATF and the Alcohol and Tobacco Tax and Trade Bureau (TTB). There will also be a role for the Treasury and the Consumer Product Safety Commission. The fate of the SAFE Banking Act to enhance banking access for cannabis companies, which Sen. Some Thoughts.
Expert insights. Personalized for you.
105 
Let's personalize your content